Fundraising FoxParagon Biosciences Evozyne Holdings
Chicago, US · Founded 2019 · Delaware LLC
Find your way into Paragon Biosciences Evozyne Holdings
Sign up to see every warm intro you have to Paragon Biosciences Evozyne Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paragon Biosciences Evozyne Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PJ
Patrick J. MorrisNamed on SEC filing
DP
Darien ParhadTreasurer
Reported raises · per SEC filings
Form D private placements$9M disclosed across 1 round · 2020
▶$9MraisedMay 2020 · 26 investors · BiotechnologyRule 506(b)
▶$9MraisedMay 2020 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Patrick J. MorrisExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $9M
- Minimum investment
- $10K
- First sale
- Apr 2020
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Paragon Biosciences Evozyne Holdings raised?
- Paragon Biosciences Evozyne Holdings has disclosed $9M raised across 1 round.
- Where is Paragon Biosciences Evozyne Holdings headquartered?
- Paragon Biosciences Evozyne Holdings is headquartered in Chicago, US.